Video

Help Minority Patients Overcome The Barriers To Trial Enrollment

Source: Clinical Leader
20_11_CLL_PatientDiversity_1920x1080_Clip4

Patient diversity remains a problem in clinical trials. Although FDA-approved medicines serve a diverse population of Americans, participation in clinical trials remains predominantly white and male. 

In this webinar segment, Robin Weinick, SVP & Managing Director, Americas and Global Program Officer for DIA, discusses the barriers that exist to clinical trial enrollment. Those barriers include time off from work, transportation, participation costs, and access to technology. Funding participation in trials would help but engaging with patients where they are is key to building lasting relationships. Working with key opinion leaders in minority communities is also a good way for sponsors to build trust with patients. 

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: